Trump's Tariff Threat Looms: How India's Pharma Giants Brace for a 100% Import Duty Shake-up
Regeneron's Growth Horizon: Beyond the Core, Towards New Frontiers
Celltrion Fortifies Biologics Dominance with Strategic Eli Lilly Plant Acquisition
South Korean Pharma Giant Celltrion Seals $330M Deal for Eli Lilly's U.S. Biologics Facility
Alkem Laboratories Unveils 'Perjio': A Landmark Leap in Affordable Breast Cancer Treatment in India
The Dawn of a New Era: Keytruda's Patent Cliff and the Future of Cancer Care